Bouabdallah, Krimo <br/><br/>
Temsirolimus in the treatment of mantle cell lymphoma:  frequency and management of adverse effects.  [electronic resource] 

 -  Current opinion in oncology  Mar 2013 
 - S1-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1531-703X 
<br/><br/><label>Standard No.: </label>10.1097/CCO.0b013e32835de8ee  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Humans<br/>Lymphoma, Mantle-Cell--drug therapy<br/>Sirolimus--administration & dosage